Opko Health Inc (OPK)

Apr 4, 2025, 8:00 AM EDT - 19 days ago

OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program

Mar 17, 2025, 8:57 AM EDT - 5 weeks ago

OPKO and Entera partner to develop obesity pill

Mar 11, 2025, 7:00 AM EDT - 6 weeks ago

Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

LH

Feb 27, 2025, 7:12 PM EST - 7 weeks ago

OPKO Health, Inc. (OPK) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 4:10 PM EST - 7 weeks ago

OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results

Jan 9, 2025, 11:45 AM EST - 3 months ago

OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Nov 18, 2024, 8:00 AM EST - 5 months ago

NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition Expo

NXPL

Nov 14, 2024, 6:00 AM EST - 5 months ago

NextPlat Reports $49.8 Million in Consolidated Revenue for the Nine Months Ended September 30, 2024, Representing a 136% Increase Over 2023 Results

BABA NXPL

Nov 7, 2024, 8:30 PM EST - 5 months ago

OPKO Health, Inc. (OPK) Q3 2024 Earnings Conference Call Transcript

Oct 7, 2024, 8:00 AM EDT - 7 months ago

ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program

Oct 7, 2024, 8:00 AM EDT - 7 months ago

NextPlat Secures Four-Year Extension of OPKO Healthcare E-Commerce Program in China and Agrees to the Expansion of the Program into Japan

NXPL

Sep 16, 2024, 7:30 AM EDT - 7 months ago

Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health

LH

Aug 7, 2024, 4:06 PM EDT - 9 months ago

OPKO Health Reports Second Quarter 2024 Business Highlights and Financial Results

Jul 17, 2024, 4:14 PM EDT - 10 months ago

OPKO Health and HealthCare Royalty Enter into $250 Million Note Purchase Agreement Secured by NGENLA's Profit Share Payments

May 31, 2024, 10:48 AM EDT - 11 months ago

OPKO Health to Participate in the Jefferies Global Healthcare Conference

May 7, 2024, 8:03 PM EDT - 1 year ago

OPKO Health, Inc. (OPK) Q1 2024 Earnings Call Transcript

May 7, 2024, 4:05 PM EDT - 1 year ago

OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results

May 3, 2024, 8:00 AM EDT - 1 year ago

OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024

Mar 28, 2024, 8:00 AM EDT - 1 year ago

Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business

LH

Mar 5, 2024, 8:52 AM EST - 1 year ago

AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV

Feb 27, 2024, 8:08 PM EST - 1 year ago

OPKO Health, Inc. (OPK) Q4 2023 Earnings Call Transcript

Feb 27, 2024, 4:05 PM EST - 1 year ago

OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results

Feb 22, 2024, 4:05 PM EST - 1 year ago

OPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024

Jan 9, 2024, 4:05 PM EST - 1 year ago

OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser's Option to Purchase Additional Notes

Jan 4, 2024, 11:31 PM EST - 1 year ago

OPKO Health Announces Pricing of Private Offering of $200 Million Convertible Senior Notes Due 2029

Jan 3, 2024, 5:05 PM EST - 1 year ago

OPKO Health Announces Private Offering of Convertible Senior Notes Due 2029

Nov 28, 2023, 7:00 AM EST - 1 year ago

BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing

Nov 7, 2023, 6:45 AM EST - 1 year ago

BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™

SOPH

Nov 6, 2023, 7:32 PM EST - 1 year ago

OPKO Health, Inc. (OPK) Q3 2023 Earnings Call Transcript

Nov 6, 2023, 4:05 PM EST - 1 year ago

OPKO Health Reports Third Quarter 2023 Business Highlights and Financial Results

Nov 2, 2023, 10:00 AM EDT - 1 year ago

New Clinical Data on OPKO Health's RAYALDEE® (ER Calcifediol) Presented at Kidney Week 2023

Oct 31, 2023, 8:00 AM EDT - 1 year ago

OPKO Health to Report Third Quarter 2023 Financial Results on November 6, 2023

Oct 25, 2023, 4:25 PM EDT - 1 year ago

OPKO Health to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023

Oct 20, 2023, 1:30 PM EDT - 1 year ago

OPKO Health: FDA Approval To Save The Company

Sep 28, 2023, 4:08 PM EDT - 1 year ago

ModeX Therapeutics Secures BARDA Contract to Develop Novel Multispecific Antibodies Against Viral Infectious Disease Threats

Aug 4, 2023, 12:17 AM EDT - 1 year ago

OPKO Health, Inc. (OPK) Q2 2023 Earnings Call Transcript

Jul 31, 2023, 2:19 PM EDT - 1 year ago

OPKO Health: Improving Profitability Should Drive Shares Forward Post Q2 Earnings

Jul 25, 2023, 4:05 PM EDT - 1 year ago

OPKO Health to Report Second Quarter 2023 Financial Results on August 3, 2023

Jun 28, 2023, 6:45 AM EDT - 1 year ago

FDA Approves Pfizer's NGENLA™, a Long-Acting Once-Weekly Treatment for Pediatric Growth Hormone Deficiency

PFE

May 11, 2023, 12:29 PM EDT - 2 years ago

OPKO Health's Future After Merck Deal: Bright Or Uncertain

MRK

May 3, 2023, 8:42 PM EDT - 2 years ago

OPKO Health, Inc. (OPK) Q1 2023 Earnings Call Transcript

May 3, 2023, 4:05 PM EDT - 2 years ago

OPKO Health Reports First Quarter 2023 Business Highlights and Financial Results

Apr 26, 2023, 12:15 AM EDT - 2 years ago

Strong Small-Cap Insider Buys: Q1 2023

AAT ABBV BY CCB CCO CMP ENVX

Apr 25, 2023, 4:05 PM EDT - 2 years ago

OPKO Health to Report First Quarter 2023 Financial Results on May 3, 2023

Feb 23, 2023, 8:56 PM EST - 2 years ago

OPKO Health, Inc. (OPK) Q4 2022 Earnings Call Transcript

Feb 23, 2023, 4:05 PM EST - 2 years ago

OPKO Health Reports Fourth Quarter 2022 Business Highlights and Financial Results

Feb 16, 2023, 11:41 AM EST - 2 years ago

OPKO Health to Report Fourth Quarter 2022 Financial Results on February 23, 2023

Feb 9, 2023, 7:05 AM EST - 2 years ago

BioReference Now Offers the Only FDA-Approved Dual-Stain Triage Test to Enhance Cervical Cancer Screenings

Jan 3, 2023, 8:00 AM EST - 2 years ago

OPKO Health to Present at the 41st Annual J.P. Morgan Healthcare Conference

Nov 8, 2022, 8:00 PM EST - 2 years ago

OPKO Health, Inc. (OPK) Q3 2022 Earnings Call Transcript